h lundbeck a/s
(LUN:Copenhagen Stock Exchange)
Transactions by H LUNDBECK A/S (LUN) in the last 6 months
H. Lundbeck A/S (CPSE:LUN) entered into a definitive agreement to acquire Chelsea Therapeutics International Ltd. (NasdaqCM:CHTP) for approximately $520 million in cash on May 7, 2014. Under the terms of agreement, H. Lundbeck Lundbeck will commence a tender offer for all outstanding shares of Chelsea, whereby Chelsea stockholders will be offered an upfront payment and contingent value rights (CVR), representing a total potential consideration of up to $7.94 per share. ...
Perceptive Advisors LLC
Visium Asset Management, LLC
Torreya Partners LLC
H. Lundbeck A/S (CPSE:LUN) announces a share repurchase program. Under the plan, the company will repurchase up to 10% of its share capital. The shares will be repurchased at a price that may not deviate by more than 10% from the price as quoted on the Nasdaq OMX Copenhagen A/S as on the date of the repurchase. The program will expire at the next Annual General Meeting.
The shareholders of H. Lundbeck A/S have authorized a buyback plan on March 26, 2014.
On March ...
|Alkermes PLC||$48.71 USD||+0.77|
|Emergent Biosolutions Inc||$23.15 USD||+0.02|
|Impax Laboratories Inc||$29.32 USD||+0.52|
|Lupin Ltd||1,037 INR||-1.40|
|Salix Pharmaceuticals Ltd||$133.29 USD||-3.98|
|View Industry Companies|